Primary eosinophilic disorders: A concise review

Medicine & Life Sciences

• Hypereosinophilic Syndrome 100%
• Pdgfra-Associated Chronic Eosinophilic Leukemia 60%
• Platelet-Derived Growth Factor Receptors 45%
• mepolizumab 19%
• Receptor, Fibroblast Growth Factor, Type 1 16%
• Investigational Drugs 16%
• Alemtuzumab 16%
• Abnormal Karyotype 15%
• Platelet-Derived Growth Factor beta Receptor 15%
• Interferon alpha-2 15%
• Neoplasms 14%
• Hydroxyurea 14%
• Imatinib Mesylate 13%
• Eosinophilia 12%
• Cytogenetics 11%
• Adrenal Cortex Hormones 9%
• Steroids 8%
• Bone Marrow 8%
• Observation 8%
• Phenotype 6%
• Safety 6%
• Mutation 6%
• Therapeutics 3%